Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03044613
Title Nivolumab or Nivolumab/Ipilimumab Prior to Chemoradiation Plus Nivolumab With II/III Gastro/Esophageal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Alleghany Health Network Pittsburgh Pennsylvania 15212 United States Details
Baylor University/ Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field